AstraZeneca AB (manufacturing, quality control and batch release)
UkraineAll drugs from this manufacturer
-
The drug is used for the treatment of bronchial asthma, exacerbations of chronic obstructive pulmonary disease (COPD), and very severe croup (subglottic laryngitis) in children requiring hospitalization.
Dosage form: suspension, for inhalation
Active substance Dosage budesonide 0.25 mg/ml ATC: R03BA02
-
The drug is used for the treatment of bronchial asthma, exacerbations of chronic obstructive pulmonary disease (COPD), and very severe croup (subglottic laryngitis) in children requiring hospitalization.
Dosage form: suspension, for inhalation
Active substance Dosage budesonide 0.5 mg/ml ATC: R03BA02